These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Bortezomib-mediated down-regulation of telomerase and disruption of telomere homeostasis contributes to apoptosis of malignant cells. Ci X; Li B; Ma X; Kong F; Zheng C; Björkholm M; Jia J; Xu D Oncotarget; 2015 Nov; 6(35):38079-92. PubMed ID: 26472030 [TBL] [Abstract][Full Text] [Related]
3. Ubiquitin ligase MKRN1 modulates telomere length homeostasis through a proteolysis of hTERT. Kim JH; Park SM; Kang MR; Oh SY; Lee TH; Muller MT; Chung IK Genes Dev; 2005 Apr; 19(7):776-81. PubMed ID: 15805468 [TBL] [Abstract][Full Text] [Related]
4. iRhom1 regulates proteasome activity via PAC1/2 under ER stress. Lee W; Kim Y; Park J; Shim S; Lee J; Hong SH; Ahn HH; Lee H; Jung YK Sci Rep; 2015 Jun; 5():11559. PubMed ID: 26109405 [TBL] [Abstract][Full Text] [Related]
5. Polo-like Kinase 1 (Plk1) Up-regulates Telomerase Activity by Affecting Human Telomerase Reverse Transcriptase (hTERT) Stability. Huang Y; Sun L; Liu N; Wei Q; Jiang L; Tong X; Ye X J Biol Chem; 2015 Jul; 290(30):18865-73. PubMed ID: 26070557 [TBL] [Abstract][Full Text] [Related]
6. CHIP promotes human telomerase reverse transcriptase degradation and negatively regulates telomerase activity. Lee JH; Khadka P; Baek SH; Chung IK J Biol Chem; 2010 Dec; 285(53):42033-45. PubMed ID: 20959453 [TBL] [Abstract][Full Text] [Related]
9. NF-kappaB p65 modulates the telomerase reverse transcriptase in the HepG₂ hepatoma cell line. Zuo QP; Liu SK; Li ZJ; Li B; Zhou YL; Guo R; Huang LH Eur J Pharmacol; 2011 Dec; 672(1-3):113-20. PubMed ID: 22008847 [TBL] [Abstract][Full Text] [Related]
10. Hsm3/S5b participates in the assembly pathway of the 19S regulatory particle of the proteasome. Le Tallec B; Barrault MB; Guérois R; Carré T; Peyroche A Mol Cell; 2009 Feb; 33(3):389-99. PubMed ID: 19217412 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of telomerase activity in human promyelocytic cell line using RNA interference. Miri-Moghaddam E; Deezagi A; Soheili ZS Ann Hematol; 2009 Dec; 88(12):1169-76. PubMed ID: 19415276 [TBL] [Abstract][Full Text] [Related]
12. A heterodimeric complex that promotes the assembly of mammalian 20S proteasomes. Hirano Y; Hendil KB; Yashiroda H; Iemura S; Nagane R; Hioki Y; Natsume T; Tanaka K; Murata S Nature; 2005 Oct; 437(7063):1381-5. PubMed ID: 16251969 [TBL] [Abstract][Full Text] [Related]
13. Differential regulation of telomerase activity by six telomerase subunits. Chang JT; Chen YL; Yang HT; Chen CY; Cheng AJ Eur J Biochem; 2002 Jul; 269(14):3442-50. PubMed ID: 12135483 [TBL] [Abstract][Full Text] [Related]
14. Human telomerase reverse transcriptase regulates MMP expression independently of telomerase activity via NF-κB-dependent transcription. Ding D; Xi P; Zhou J; Wang M; Cong YS FASEB J; 2013 Nov; 27(11):4375-83. PubMed ID: 23884427 [TBL] [Abstract][Full Text] [Related]
15. NOXA, a sensor of proteasome integrity, is degraded by 26S proteasomes by an ubiquitin-independent pathway that is blocked by MCL-1. Craxton A; Butterworth M; Harper N; Fairall L; Schwabe J; Ciechanover A; Cohen GM Cell Death Differ; 2012 Sep; 19(9):1424-34. PubMed ID: 22361683 [TBL] [Abstract][Full Text] [Related]
16. Assembly and function of the proteasome. Saeki Y; Tanaka K Methods Mol Biol; 2012; 832():315-37. PubMed ID: 22350895 [TBL] [Abstract][Full Text] [Related]
17. Proteasomal ATPase-associated factor 1 negatively regulates proteasome activity by interacting with proteasomal ATPases. Park Y; Hwang YP; Lee JS; Seo SH; Yoon SK; Yoon JB Mol Cell Biol; 2005 May; 25(9):3842-53. PubMed ID: 15831487 [TBL] [Abstract][Full Text] [Related]
18. Subunit-subunit interactions in the human 26S proteasome. Chen C; Huang C; Chen S; Liang J; Lin W; Ke G; Zhang H; Wang B; Huang J; Han Z; Ma L; Huo K; Yang X; Yang P; He F; Tao T Proteomics; 2008 Feb; 8(3):508-20. PubMed ID: 18186020 [TBL] [Abstract][Full Text] [Related]
19. Amplification of hTERT and hTERC genes in leukemic cells with high expression and activity of telomerase. Nowak T; Januszkiewicz D; Zawada M; Pernak M; Lewandowski K; Rembowska J; Nowicka K; Mankowski P; Nowak J Oncol Rep; 2006 Aug; 16(2):301-5. PubMed ID: 16820907 [TBL] [Abstract][Full Text] [Related]
20. Structure-Driven Developments of 26S Proteasome Inhibitors. Śledź P; Baumeister W Annu Rev Pharmacol Toxicol; 2016; 56():191-209. PubMed ID: 26738474 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]